Is Kidney Transplantation a Better State of CKD? Impact on Diagnosis and Management
- PMID: 27742382
- DOI: 10.1053/j.ackd.2016.09.006
Is Kidney Transplantation a Better State of CKD? Impact on Diagnosis and Management
Abstract
Patients with CKD are at increased risk for cardiovascular events, hospitalizations, and mortality. Kidney transplantation (KTx) is the preferred treatment for end-stage kidney disease. Although comorbidities including anemia and bone and mineral disease improve or are even halted after KTx, kidney transplant recipients carry higher cardiovascular mortality risk than the general population, as well as an increased risk of infections, malignancies, fractures, and obesity. When comparing CKD with CKD after transplantation (CKD-T), the rate of decline of estimated glomerular filtration rate (eGFR) is significantly lower in CKD-T. Higher rate of decline of eGFR has been associated with increased risk of mortality. However, due to the significant increased risk of mortality due to cardiovascular events, infections, and malignancies, many kidney transplant recipients may not benefit of decline in the rate of eGFR. Patients with CKD-T are a unique subset of patients with multiple traditional and transplant-specific risk factors. Proper management and appropriate preventive health measures may improve long-term patient and allograft survival in patients with CKD-T.
Keywords: CKD; CKD-T; ESRD; Kidney transplant.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Prevalence of chronic kidney disease in orthotopic heart transplant recipients and kidney allograft recipients using the new Chronic Kidney Disease Epidemiology Collaboration formula.Transplant Proc. 2010 Dec;42(10):4251-4. doi: 10.1016/j.transproceed.2010.09.033. Transplant Proc. 2010. PMID: 21168676
-
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.Curr Opin Nephrol Hypertens. 2014 May;23(3):306-13. doi: 10.1097/01.mnh.0000444912.40418.45. Curr Opin Nephrol Hypertens. 2014. PMID: 24670404 Review.
-
Anemia in Patients After Stem Cell Transplantation and in Kidney Transplant Recipients.Transplant Proc. 2024 May;56(4):961-964. doi: 10.1016/j.transproceed.2024.03.028. Epub 2024 May 4. Transplant Proc. 2024. PMID: 38705734
-
Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905. Clin Nephrol. 2013. PMID: 23993165
-
Early diagnosis of CKD and its prevention.J Assoc Physicians India. 2008 Jan;56:41-6. J Assoc Physicians India. 2008. PMID: 18472500 Review.
Cited by
-
Twelve Thousand Kidney Transplants Over More Than 55 Y: A Single-center Experience.Transplant Direct. 2024 Jan 19;10(2):e1575. doi: 10.1097/TXD.0000000000001575. eCollection 2024 Feb. Transplant Direct. 2024. PMID: 38264296 Free PMC article.
-
The gut microbiome and metabolome in kidney transplant recipients with normal and moderately decreased kidney function.Ren Fail. 2023 Dec;45(1):2228419. doi: 10.1080/0886022X.2023.2228419. Ren Fail. 2023. PMID: 37381833 Free PMC article.
-
Predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019: A systematic review and meta-analysis.Transpl Immunol. 2023 Feb;76:101739. doi: 10.1016/j.trim.2022.101739. Epub 2022 Nov 19. Transpl Immunol. 2023. PMID: 36414181 Free PMC article. Review.
-
Role of novel biomarkers in kidney transplantation.World J Transplant. 2020 Sep 18;10(9):230-255. doi: 10.5500/wjt.v10.i9.230. World J Transplant. 2020. PMID: 32995319 Free PMC article. Review.
-
Perspectives in Individualizing Solutions for Dialysis Access.Adv Chronic Kidney Dis. 2020 May;27(3):183-190. doi: 10.1053/j.ackd.2020.03.004. Adv Chronic Kidney Dis. 2020. PMID: 32891301 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous